Nephros Statistics
Share Statistics
Nephros has 10.54M shares outstanding. The number of shares has increased by 0.56% in one year.
| Shares Outstanding | 10.54M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 9.24M |
| Failed to Deliver (FTD) Shares | 59 |
| FTD / Avg. Volume | 0.51% |
Short Selling Information
The latest short interest is 626, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 626 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 0.04 |
Valuation Ratios
The PE ratio is -22.82 and the forward PE ratio is 164.
| PE Ratio | -22.82 |
| Forward PE | 164 |
| PS Ratio | 2.52 |
| Forward PS | 1.1 |
| PB Ratio | 4.3 |
| P/FCF Ratio | 47.79 |
| PEG Ratio | n/a |
Enterprise Valuation
Nephros Inc. has an Enterprise Value (EV) of 33.46M.
| EV / Earnings | -21.25 |
| EV / Sales | 2.35 |
| EV / EBITDA | -24.27 |
| EV / EBIT | -21.01 |
| EV / FCF | 44.5 |
Financial Position
The company has a current ratio of 3.98, with a Debt / Equity ratio of 0.22.
| Current Ratio | 3.98 |
| Quick Ratio | 2.81 |
| Debt / Equity | 0.22 |
| Total Debt / Capitalization | 18.01 |
| Cash Flow / Debt | 0.45 |
| Interest Coverage | -796.5 |
Financial Efficiency
Return on equity (ROE) is -0.19% and return on capital (ROIC) is -15.63%.
| Return on Equity (ROE) | -0.19% |
| Return on Assets (ROA) | -0.13% |
| Return on Capital (ROIC) | -15.63% |
| Revenue Per Employee | 459.29K |
| Profits Per Employee | -50.81K |
| Employee Count | 31 |
| Asset Turnover | 1.2 |
| Inventory Turnover | 2.36 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -44.44% in the last 52 weeks. The beta is 1.19, so Nephros 's price volatility has been higher than the market average.
| Beta | 1.19 |
| 52-Week Price Change | -44.44% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.98 |
| Relative Strength Index (RSI) | 46.78 |
| Average Volume (20 Days) | 11.68K |
Income Statement
In the last 12 months, Nephros had revenue of $14.24M and earned -$1.57M in profits. Earnings per share was $-0.15.
| Revenue | 14.24M |
| Gross Profit | 8.40M |
| Operating Income | -1.59M |
| Net Income | -1.57M |
| EBITDA | -1.38M |
| EBIT | -1.59M |
| Earnings Per Share (EPS) | -0.15 |
Balance Sheet
The company has $4.31M in cash and $1.84M in debt, giving a net cash position of $2.47M.
| Cash & Cash Equivalents | 4.31M |
| Total Debt | 1.84M |
| Net Cash | 2.47M |
| Retained Earnings | -144.41M |
| Total Assets | 10.39M |
| Working Capital | 6.30M |
Cash Flow
In the last 12 months, operating cash flow was $827.00K and capital expenditures -$75.00K, giving a free cash flow of $752.00K.
| Operating Cash Flow | 827.00K |
| Capital Expenditures | -75.00K |
| Free Cash Flow | 752.00K |
| FCF Per Share | 0.07 |
Margins
Gross margin is 59.03%, with operating and profit margins of -11.19% and -11.06%.
| Gross Margin | 59.03% |
| Operating Margin | -11.19% |
| Pretax Margin | -11.06% |
| Profit Margin | -11.06% |
| EBITDA Margin | -9.69% |
| EBIT Margin | -11.19% |
| FCF Margin | 5.28% |
Dividends & Yields
NEPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -9.37% |
| FCF Yield | 4.46% |
Analyst Forecast
Currently there are no analyst rating for NEPH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 10, 2019. It was a backward split with a ratio of 1:9.
| Last Split Date | Jul 10, 2019 |
| Split Type | backward |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | -13.18 |
| Piotroski F-Score | 3 |